1–10 of 11 results for Prithvi Mruthyunjaya
A Phase 2 Safety and Efficacy Trial of AU-011, a Virus-Like Drug Conjugate, With Dose Escalation and Randomized Masked Expansion in Uveal Melanoma
Prithvi Mruthyunjaya, MD, MHS
Annual Meeting Talks
2021
Impact of PRAME Status on Gene Expression Profile to Predict Metastasis in Uveal Melanoma: Interim Analysis of the Collaborative Ocular Oncology Group Study Number 2 (COOG2)
Updates from the Field
2022
Using ‘Big Data’ to characterize uveal tumor treatment pathways and their complications in a cohort of commercially insured patients
On Demand Cases, Courses, and Papers
2019
Surgical Case Conference Prithvi Mruthyunjaya
Targeted Attack of an Aggressive Peripapillary Astrocytic Hamartoma
2016
Structural Outcomes and Imaging Observations Following Scleral Window to Treat Exudative Detachment in Uveal Effusion Syndrome
2018
Episode 133: Ocular Oncology Meets Vitreoretinal Surgery with Dr. Prithvi Mruthyunjaya
Jayanth Sridhar, MD
Member Podcasts
Part 2: Vitreous, Retina, and Choroidal Biopsies: Surgical and Pathologic Techniques, Commercial Options for Analyses, and Update on Recent Studies
Amy C. Schefler, MD FACS FASRS
Thomas M. Aaberg Jr. , MD
Zelia M. Correa, MD, PhD
Ivana K. Kim, MD
2017
Part 1: Vitreous, Retina, and Choroidal Biopsies: Surgical and Pathologic Techniques, Commercial Options for Analyses, and Update on Recent Studies